Are nerve conduction studies safe in patients with implanted pacemakers?

Safety of Nerve Conduction Studies in Pacemaker Patients

Nerve conduction studies (NCS) are safe in patients with implanted pacemakers when using bipolar sensing configurations, but require specific precautions in patients with unipolar sensing or pacemaker dependency.

Key Safety Evidence

The most recent high-quality research demonstrates that routine NCS can be performed safely in pacemaker patients 1. In a prospective study of 10 patients with dual-chamber pacemakers and 5 with ICDs, electrical impulses from NCS were never detected by the sensing amplifier and did not affect programmed device settings when bipolar sensing was used 1.

However, critical distinctions exist based on sensing configuration:

Bipolar vs. Unipolar Sensing

• Bipolar sensing: NCS is safe without special precautions 2, 1
• Unipolar sensing: Electromagnetic interference (EMI) can cause pacing inhibition and pauses 2

In a 2013 prospective study, EMI was observed in 3 of 4 pacemakers during repetitive nerve stimulation, leading to pacing inhibition in 2 patients—both programmed to unipolar sensing 2. No such problems occurred with bipolar configurations.

Practical Protocol for Safe NCS

Pre-Procedure Assessment

1. Identify device type: Determine if patient has pacemaker vs. ICD
2. Check sensing configuration: Verify bipolar vs. unipolar lead system
3. Assess pacemaker dependency: Review underlying rhythm and determine if patient requires continuous pacing
4. Interrogate device: Document baseline settings, battery status, and sensing thresholds

During the Procedure

For patients with bipolar sensing (majority of modern devices):

• Proceed with standard NCS technique
• No magnet placement required 3
• Continuous ECG monitoring recommended but not mandatory

For patients with unipolar sensing:

• Consider reprogramming to asynchronous mode (VOO/DOO) if pacemaker-dependent 4
• Maintain continuous ECG monitoring
• Keep stimulation sites as far from pulse generator as possible
• Use shortest stimulus duration and lowest intensity necessary

For all patients:

• Avoid placing stimulating electrodes directly over the pulse generator
• Confine current paths to standard clinical parameters 5

Post-Procedure

• Interrogate device to verify unchanged settings
• Check for any threshold changes or mode switches
• Document any EMI detected during study

Device-Specific Considerations

ICDs

NCS is particularly safe with ICDs—no spurious tachyarrhythmia detection occurred even when EMI was visible 2. The higher sensing thresholds for tachyarrhythmia detection make ICDs less susceptible to NCS interference.

Modern vs. Older Devices

Newer pacemakers have improved shielding and circuitry, making them less vulnerable to EMI 5. However, the fundamental principles remain: bipolar sensing provides superior noise rejection compared to unipolar configurations.

Common Pitfalls to Avoid

1. Unnecessary magnet placement: A 2013 study found magnet application increased patient symptoms 11-fold without improving safety 3. Magnets are not routinely necessary for NCS.

2. Deferring necessary testing: Anxiety about device interference should not prevent clinically indicated electrodiagnostic studies 1, 6

3. Assuming all pacemakers are the same: Always verify sensing configuration—this is the critical safety determinant

4. Inadequate monitoring in unipolar systems: These require heightened vigilance for pacing inhibition

Comparison with Other Electrical Procedures

The guidelines distinguish NCS from higher-risk procedures 7, 4:

• Electrocautery: Requires device reprogramming, asynchronous mode for pacemaker-dependent patients
• MRI: Contraindicated in older devices, requires specialized protocols
• Transcutaneous electrical nerve stimulation (TENS): Uses higher frequencies and is NOT recommended in ICD patients 8

NCS uses much lower energy and frequency than these modalities, contributing to its favorable safety profile.

Evidence Quality Assessment

The safety data comes from multiple prospective studies with direct device interrogation 2, 1, providing Level B evidence. While guideline documents address electromagnetic interference broadly 7, 4, 9, the specific research on NCS consistently demonstrates safety when appropriate precautions are followed.

The bottom line: Proceed with standard NCS in patients with bipolar sensing. Exercise caution only in the minority with unipolar sensing or pacemaker dependency, where reprogramming and continuous monitoring become essential.